Zum Hauptinhalt springen
| Hans-Günter Meyer-Thompson | Legal

USA. Purdue Pharma Can Protect Sackler Owners in Opioid Bankruptcy, Court Rules

Purdue Pharma Can Protect Sackler Owners in Opioid Bankruptcy, Court Rules

NEW YORK (Reuters) - Bankrupt OxyContin maker Purdue Pharma can shield its owners, members of the wealthy Sackler family, from opioid lawsuits in exchange for a $6 billion contribution to the company's broader bankruptcy settlement, a U.S. appeals court ruled on Tuesday. (Reuters, USA, 01.06.2023)

https://www.medscape.com/viewarticle/992544